🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the companies concealed potential risks that the medication created to pediatric cognitive development.

The lawsuit arrives thirty days after Former President Trump promoted an unsubstantiated connection between using Tylenol - also known as paracetamol - throughout gestation and autism in young ones.

Paxton is filing suit against Johnson & Johnson, which once produced the medication, the sole analgesic approved for expectant mothers, and Kenvue, which now manufacturers it.

In a declaration, he said they "misled consumers by making money from discomfort and promoting medication ignoring the risks."

Kenvue asserts there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, deliberately risking countless individuals to line their pockets," Paxton, a Republican, said.

Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the health of American women and children."

On its official site, Kenvue also said it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between using paracetamol and autism spectrum disorder."

Associations speaking for doctors and medical practitioners share this view.

ACOG has said acetaminophen - the primary component in acetaminophen - is one of the few options for expectant mothers to manage pain and fever, which can present major wellness concerns if left untreated.

"In multiple decades of research on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the usage of acetaminophen in any stage of pregnancy causes brain development issues in children," the association commented.

This legal action mentions recent announcements from the previous government in arguing the medication is allegedly unsafe.

Last month, Trump caused concern from public health officials when he advised women during pregnancy to "struggle intensely" not to use acetaminophen when unwell.

The US Food and Drug Administration then released a statement that doctors should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in spring to undertake "extensive scientific investigation" that would determine the cause of autism spectrum disorder in a matter of months.

But specialists cautioned that discovering a unique factor of autism spectrum disorder - thought by researchers to be the result of a complex mix of genetic and environmental factors - would be difficult.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that influences how people perceive and engage with the environment, and is recognized using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is seeking US Senate - claims Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the evidence" around paracetamol and autism.

This legal action seeks to make the companies "remove any commercial messaging" that claims Tylenol is safe for pregnant women.

This legal action mirrors the grievances of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in recently.

A federal judge dismissed the legal action, declaring investigations from the parents' expert witnesses was inconclusive.